Pretreatment
PSA
|
|
|
|
PSA
LEVELS OF 20 - 100 ng / mL
|
|
.
|
Iwamoto H, Izumi K, Kadono Y, Mizokami A.
Prognosis of
patients with prostate cancer and middle range prostate - specific
antigen levels of 20 - 100 ng / mL.
Int Braz J Urol.
2019 Jan-Feb;45(1):61-67. doi: 10.1590/S1677-5538.IBJU.2018.0143.
Epub 2918 Oct 30.
Source
| Full
text |
Similar
articles
|
|
|
.
|
Joob B, Wiwanitkit V.
Re: Prognosis of prostate cancer
and prostate - specific antigen levels.
Int Braz J Urol.
2019 Mar 20;45. doi: 10.1590/S1677-5538.IBJU.2018.0867. [Epub
ahead of print]
Source
| Full
text |
Similar
articles
Refers
to: Iwamoto H, et al., Prognosis of patients with prostate cancer
and middle range prostate - specific antigen levels of 20 - 100 ng
/ mL.
Int Braz J Urol. 2019 Jan-Feb;45(1):61-67. doi:
10.1590/S1677-5538.IBJU.2018.0143. Epub 2918 Oct 30.
Source
|
Full
text
|
|
|
BIOCHEMICAL
AND CLINICAL FAILURES
|
|
.
|
Kupelian
PA, Katcher J, Levin HS, Klein EA.
Stage
T1-2 prostate cancer: a multivariate analysis of factors affecting
biochemical and clinical failures after radical prostatectomy.
Int
J Radiat Oncol Biol Phys. 1997 Mar 15;37(5):1043-52. DOI:
http://dx.doi.org/10.1016/S0360-3016(96)00590-1
Source
|
Full
text |
Similar
articles
|
|
|
.
|
Santok
GD, Abdel Raheem A, Kim LH, Chang K, Lum TG, Chung BH, Choi YD,
Rha KH.
Prostate-specific
antigen 10-20 ng/mL: A predictor of degree of upgrading to ≥8
among patients with biopsy Gleason score 6.
Investig
Clin Urol. 2017 Mar;58(2):90-97. doi: 10.4111/icu.2017.58.2.90.
Epub 2017 Feb 15.
Source
|
Full
text |
Similar
articles
|
|
|
PREOPERATIVE
PSA VELOCITY
|
|
.
|
Patel
DA, Presti JC Jr, McNeal JE, Gill H, Brooks JD, King CR.
Preoperative
PSA velocity is an independent prognostic factor for relapse after
radical prostatectomy.
J
Clin Oncol. 2005 Sep 1;23(25):6157-62. DOI:
10.1200/JCO.2005.01.2336
Source
| Full
text |
Similar
articles
|
|
|
STATIN
USE
|
|
|
Hamilton
RJ, Goldberg KC, Platz EA, Freedland SJ.
The
influence of statin medications on prostate-specific antigen
levels.
J
Natl Cancer Inst. 2008 Nov 5;100(21):1511-8. doi:
10.1093/jnci/djn362
Source
|
Full
text |
Similar
articles
|
|
|
PREDICTION
OF METASTASES
|
|
.
|
Singh OP, Yogi V, Redhu P, Ghori HU, Pareek A, Lal N.
Role
of serum prostate-specific antigen as predictor for bone
metastases in newly diagnosed prostate cancer.
J Cancer
Res Ther. 2019 Mar;15(Supplement):S39-S41. doi:
10.4103/jcrt.JCRT_189_18.
Source
| Full
text |
Similar
articles
|
|
|
|
|
|
|